DARATUMUMAB 100MG/20ML INJECTION

Daratumumab 100mg/20ml Injection is a prescription monoclonal antibody therapy used as a targeted cancer treatment. It is specifically designed for patients with multiple myeloma, helping to inhibit cancer cell growth and improve treatment outcomes. This injection is administered under strict medical supervision in hospital settings to ensure safe and effective therapy.

Daratumumab works by targeting the CD38 protein found on multiple myeloma cells. By doing so, it activates the immune system to identify and destroy cancerous cells, making it a highly effective targeted oncology treatment. The therapy can be used alone or in combination with other anticancer medicines, providing a flexible treatment approach for doctors and patients.

As a hospital-administered prescription medicine, Daratumumab Injection requires careful monitoring during treatment to ensure optimal safety and efficacy. It is a vital option for patients seeking advanced multiple myeloma treatment under professional medical care.

Product Features

• Targeted monoclonal antibody therapy
• Contains Daratumumab
• Strength: 100 mg / 20 mL
• Used in the treatment of multiple myeloma
• Sterile formulation
• Administered via intravenous infusion
• Manufactured under stringent pharmaceutical quality standards
• Prescription-required oncology medicine

How It Helps

• Targets the CD38 protein on cancer cells to support the immune system’s attack.
• Helps slow down or stop the growth of multiple myeloma cells.
• Can be used alone or with other anticancer medicines for effective treatment.
• Administered under strict medical supervision to ensure safety and efficacy.